Does Ultrasound Assessment for Extravascular Lung Water and IVC Measurement Affect Outcomes in Inpatient Heart Failure Management?

Overseen By Michael Ulrich, MD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Riverside University Health System Medical Center

Must be taking: Diuretics

Disqualifiers: ICU admission, Positive pressure ventilation, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 1 week

400 Participants Needed

Trial Summary

What is the purpose of this trial?

This trial uses a daily device to help doctors control fluid levels in patients with serious heart conditions. The goal is to make better treatment choices and lower the risk of kidney problems.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the study team or your doctor.

Eligibility Criteria

Inclusion Criteria

Age >18 admitted for acute decompensated heart failure exacerbation as primary admission diagnosis from Emergency department to General Medicine ward that are administered diuretic therapy expected to be admitted for two days or more.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 week

Treatment

Participants receive daily POCUS/FCU exams and IV diuretics for acute decompensated heart failure management

1 week

Daily visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

• Daily POCUS Exam

Participant Groups

Group I: Daily POCUS Experimental Treatment 1 Intervention

Patients are assessed by facility experts with daily chest ultrasound and findings of interstitial syndrome and IVC measurement are reported to primary care providers.

Group II: Usual care Active Control 1 Intervention

Patients are assessed daily by primary care providers per usual care.

Who Is Running the Clinical Trial?

Riverside University Health System Medical Center

Lead Sponsor

Trials

10

Recruited

19,300+